Keller G - Search Results

1

DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.

Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R. Ott K, et al. Among authors: keller g. Ann Surg Oncol. 2011 Sep;18(9):2688-98. doi: 10.1245/s10434-011-1601-y. Epub 2011 Feb 24. Ann Surg Oncol. 2011. PMID: 21347786

2

Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history.

Keller G, Rotter M, Vogelsang H, Bischoff P, Becker KF, Mueller J, Brauch H, Siewert JR, Höfler H. Keller G, et al. Am J Pathol. 1995 Sep;147(3):593-600. Am J Pathol. 1995. PMID: 7677173 Free PMC article.

3

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.

Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, Grundei T, Becker KF, Mueller J, Siewert JR, Höfler H. Keller G, et al. Am J Pathol. 1999 Aug;155(2):337-42. doi: 10.1016/S0002-9440(10)65129-2. Am J Pathol. 1999. PMID: 10433926 Free PMC article.

4

Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.

Grundei T, Vogelsang H, Ott K, Mueller J, Scholz M, Becker K, Fink U, Siewert JR, Höfler H, Keller G. Grundei T, et al. Among authors: keller g. Clin Cancer Res. 2000 Dec;6(12):4782-8. Clin Cancer Res. 2000. PMID: 11156235

5

Gastric adenocarcinoma: pathomorphology and molecular pathology.

Werner M, Becker KF, Keller G, Höfler H. Werner M, et al. Among authors: keller g. J Cancer Res Clin Oncol. 2001 Apr;127(4):207-16. doi: 10.1007/s004320000195. J Cancer Res Clin Oncol. 2001. PMID: 11315254 Review.

6

The use of molecular biology in diagnosis and prognosis of gastric cancer.

Becker KF, Keller G, Hoefler H. Becker KF, et al. Among authors: keller g. Surg Oncol. 2000 Jul;9(1):5-11. doi: 10.1016/s0960-7404(00)00016-5. Surg Oncol. 2000. PMID: 11525306 Review.

7

[Response prediction: molecular approaches and routine clinical care].

Vogelsang H, Keller G, Ott K, Theisen J, Weber W, Fink U, Becker K, Höfler H, Siewert JR. Vogelsang H, et al. Among authors: keller g. Z Gastroenterol. 2003 Mar;41 Suppl 1:S18-9. doi: 10.1055/s-2003-37428. Z Gastroenterol. 2003. PMID: 12664335 German. No abstract available.

8

Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.

Ott K, Vogelsang H, Mueller J, Becker K, Müller M, Fink U, Siewert JR, Höfler H, Keller G. Ott K, et al. Among authors: keller g. Clin Cancer Res. 2003 Jun;9(6):2307-15. Clin Cancer Res. 2003. PMID: 12796400

9

Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.

Napieralski R, Ott K, Kremer M, Specht K, Vogelsang H, Becker K, Müller M, Lordick F, Fink U, Rüdiger Siewert J, Höfler H, Keller G. Napieralski R, et al. Among authors: keller g. Clin Cancer Res. 2005 Apr 15;11(8):3025-31. doi: 10.1158/1078-0432.CCR-04-1605. Clin Cancer Res. 2005. PMID: 15837757 Clinical Trial.

10

The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.

Baumann S, Keller G, Pühringer F, Napieralski R, Feith M, Langer R, Höfler H, Stein HJ, Sarbia M. Baumann S, et al. Among authors: keller g. Int J Cancer. 2006 Jul 15;119(2):264-8. doi: 10.1002/ijc.21848. Int J Cancer. 2006. PMID: 16477636 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

946 results

Search Page